Sign in
De novo design of chiral organotin cancer drug candidates: Validation of enantiopreferential binding to molecular target DNA and 5 '-GMP by UV-visible, fluorescence, H-1 and P-31 NMR
Journal article   Peer reviewed

De novo design of chiral organotin cancer drug candidates: Validation of enantiopreferential binding to molecular target DNA and 5 '-GMP by UV-visible, fluorescence, H-1 and P-31 NMR

Farukh Arjmand, Girish Chandra Sharma, Fatima Sayeed, Mohd Muddassir and Sartaj Tabassum
Journal of photochemistry and photobiology. B, Biology, Vol.105(3), pp.167-174
02/12/2011
PMID: 21945056

Abstract

Biochemistry & Molecular Biology Biophysics Life Sciences & Biomedicine Science & Technology

Metrics

1 Record Views

Details